COMMUNIQUÉS West-GlobeNewswire

Immunicum AB (publ) Announces Upcoming Investor Events in February

01/02/2019 - 08:01

Press Release 1 February 2019 Immunicum AB (publ) Announces Upcoming Investor Events in February Immunicum AB (publ; IMMU.ST) announced today that Carlos de Sousa, CEO of Immunicum, and other members of the management [...]

Novo Nordisk's operating profit decreased by 4% in Danish kroner and increased by 3% in local currencies in 2018

01/02/2019 - 07:32

Operating profit increased by 6% measured in local currencies when adjusted for the cost of severance and the priority review voucher for oral semaglutide Sales remained broadly unchanged in Danish kroner and increased [...]

DBV Technologies to Present at the 8th Annual Leerink Partners Global Healthcare Conference

01/02/2019 - 07:31

Montrouge, France, February 1, 2019 DBV Technologies to Present at the 8 th Annual Leerink Partners Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a [...]

DBV Technologies invitée à presenter à la 8th Annual Leerink Partners Global Healthcare Conference

01/02/2019 - 07:31

Montrouge, France, le 1 février (7h30 CET), 2019 DBV Technologies invitée à presenter à la 8 th Annual Leerink Partners Global Healthcare Conference DBV Technologies (Euronext: DBV - ISIN : FR0010417345 - Nasdaq Stock [...]

Biocartis Group NV: Disclosure of a transparency notification

01/02/2019 - 07:02

PRESS RELEASE: REGULATED INFORMATION 1 February 2019, 07:00 CET Disclosure of a transparency notification Mechelen, Belgium, 1 February 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]

Hua Medicine Initiates First Combination Study of Dorzagliatin with a DPP-4 Inhibitor in the United States

01/02/2019 - 05:34

SHANGHAI, China, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Hua Medicine (“Hua” or “the Company”; Stock Code: 2552.HK) a Shanghai-based drug development company focused on developing a global first-in-class oral drug for the [...]

OPKO Provides Update on the Development of OPK-88004, a Selective Androgen Receptor Modulator

01/02/2019 - 03:15

MIAMI, Jan. 31, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced an update on the ongoing development plans of OPK-88004, a selective androgen receptor modulator (SARM). OPK-88004 has the ability [...]

Future Non-Coverage Determination for 4Kscore Test Posted by Novitas

01/02/2019 - 02:00

MIAMI, Jan. 31, 2019 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that Novitas Solutions, Inc. has issued a notice of a future non-coverage determination for the 4Kscore test® to be effective [...]

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01/02/2019 - 00:00

CAMBRIDGE, Mass., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on January 31, 2019, that were previously [...]

Resverlogix Closes $6.6 Million Private Placement with Shenzhen Hepalink

01/02/2019 - 00:00

CALGARY, Alberta, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today it has closed a private placement of approximately 2.2 million equity units to Shenzhen [...]

Nuvectra® Appoints Dr. Fred B. Parks as Chief Executive Officer

31/01/2019 - 23:01

Elects Christopher G. Chavez as a Member of the Board of Directors PLANO, Texas, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ: NVTR), a neurostimulation medical device company, today announced the [...]

Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2018

31/01/2019 - 22:30

OTTAWA, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”) reported its audited financial results for the year ended October 31, 2018. Unless otherwise noted, all figures are in Canadian currency. [...]

resTORbio to Host Key Opinion Leader Symposium on TORC1 Inhibition and Neurodegenerative Disease

31/01/2019 - 22:30

BOSTON, Jan. 31, 2019 (GLOBE NEWSWIRE) -- resTORbio, Inc. (NASDAQ:TORC), a clinical-stage biopharmaceutical company developing a new class of medicines that target the biology of aging to prevent or treat age-related [...]

Milestone Scientific Announces Proposed Public Offering of Common Stock and Warrants

31/01/2019 - 22:21

LIVINGSTON, N.J., Jan. 31, 2019 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announced today that it [...]

Geron Announces Expansion of Leadership Team with Appointment of Chief Medical Officer

31/01/2019 - 22:20

Aleksandra Rizo, M.D., Ph.D., former clinical lead for the imetelstat program at Janssen, joins Geron as Chief Medical Officer Additional office to be opened in New Jersey to support expansion of clinical development [...]

The Cooper Companies Announces Release Date for First Quarter 2019

31/01/2019 - 22:15

PLEASANTON, Calif., Jan. 31, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced it will release first quarter 2019 financial results on Tuesday, March 5, 2019, at 4:15 PM ET. Following the [...]

LHC Group and Unity Health Announce Joint Venture Agreement in Arkansas

31/01/2019 - 22:15

LAFAYETTE, La., Jan. 31, 2019 (GLOBE NEWSWIRE) -- LHC Group (NASDAQ: LHCG) and Unity Health today announced finalization of an equity partnership agreement to purchase and share ownership of two home health providers in [...]

Inspire Medical Systems, Inc. Announces a Positive Coverage Policy Issued by Blue Cross Blue Shield of North Carolina

31/01/2019 - 22:15

MINNEAPOLIS, Jan. 31, 2019 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

Change in the number of shares and votes in Oasmia Pharmaceutical AB (publ)

31/01/2019 - 22:05

Oasmia Pharmaceutical AB (publ) (”Oasmia” or ”Company” or “Group”) on 18 April 2018 issued a convertible loan with a total nominal amount of MSEK 26. In total circa MSEK 7 of the convertible loan has during January 2019 [...]